PCYT2 and metabolic dysfunction-associated steatohepatitis: We also showed that supplementation with the artificial Pcyt2 substrate phosphonoethylamine (PEA) reverses Pcyt2 + /- steatosis, inflammation, and improved the dysregulation of various regulators associated with NASH pathogenesis [16].